Showing results (61-70 of 90) with videos related to
Sort By:
Pageof 9
Parkinsonism & Related Disorders|May 1, 2024
Mild cognitive impairment among LRRK2 and GBA1 patients with Parkinson's diseaseAvner Thaler, Vered Livne, Einat Rubinstein, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 1, 2014
A voxel-based morphometry and diffusion tensor imaging analysis of asymptomatic Parkinson's disease-related G2019S LRRK2 mutation carriersAvner Thaler, Moran Artzi, Anat Mirelman, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 31, 2024
White matter abnormalities in healthy E200K carriers may serve as an early biomarker for genetic Creutzfeldt-Jakob disease (gCJD)Nurit Omer, Amgad Droby, Rawan Silbak, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 22, 2021
Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or SeverityNurit Omer, Nir Giladi, Tanya Gurevich, et al.Brain : a Journal of Neurology|December 20, 2012
Cerebral pathological and compensatory mechanisms in the premotor phase of leucine-rich repeat kinase 2 parkinsonismBart F L van Nuenen, Rick C Helmich, Murielle Ferraye, et al.Parkinsonism & Related Disorders|August 29, 2024
Levodopa-carbidopa intestinal gel for advanced Parkinson's disease: Impact of LRRK2 and GBA1 mutationsAvner Thaler, Saar Anis, Penina Ponger, et al.JAMA Network Open|April 21, 2021
Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease ProgressionRoberto A Ortega, Cuiling Wang, Deborah Raymond, et al.Journal of Parkinson'S Disease|February 20, 2025
The effect of polygenic risk score on PD risk and phenotype in LRRK2 G2019S and GBA1 carriersOrly Goldstein, Shachar Shani, Mali Gana-Weisz, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 27, 2015
Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 geneAnat Mirelman, Roy N Alcalay, Rachel Saunders-Pullman, et al.JAMA Neurology|January 9, 2018
Progression in the LRRK2-Asssociated Parkinson Disease PopulationRachel Saunders-Pullman, Anat Mirelman, Roy N Alcalay, et al.Pageof 9